- Home
- Reagents
- Overview
- Primary Antibodies
- Overview
- Anti-Allergen Antibodies
- Anti-Coronavirus Antibodies
- Anti-Virus Antibodies
- Antibodies to Epitope Tags
- DNA/RNA Research Antibodies
- Immunotherapy Research Antibodies
- Murine Bispecific Antibody Reagents
- Neuroscience Research Antibodies
- Recombinant Antibodies from Human Patients
- Recombinant Isotype Controls
- Research-Grade Biosimilars
- Tumor Marker Antigens
- VivopureX™ Antibodies for In Vivo Research
- Secondary Antibodies
- Recombinant Proteins
- Services
- Our Technology
- About Us
- Antibody Resource
- News & Events
- How to Order
80
Products in this category:
Antibody Name [Clone]
Expected Species Reactivity
Applications
-
Anti-4-1BB [BBK2 ]Humanantagonist, Blocking, IP, FC, IF, IHC
-
Anti-A14 [BB5.2]Vaccinia virusIP, WB, IF
-
Anti-Capsid protein VP25 [PL-2 scFv]Human astrovirusBlocking, crystallography, IP, WB, ELISA, IF
-
Anti-Cedar virus F [19E 7]Cedar henipavirus (Cedar virus)IP, WB
-
Anti-Cedar virus G [11D5]Cedar henipavirus (Cedar virus)IP
-
Anti-Cedar virus G [14F3]Cedar henipavirus (Cedar virus)IP, neutralization, WB
-
Anti-CMV glycoprotein gB [HCMV37]CMVICC, IP, NTRL, ELISA, IF, IHC-Fr
-
Anti-CPV capsid [A3B10 (MAb 8)]canine parvovirus, feline panleukopenia virusIP, NTRL, ELISA
-
Anti-Domain II of the DENV-2 envelope protein (E) [1A5]Dengue VirusIP, neutralization, WB, ELISA
-
Anti-dsRNA [J2]Species independentIP, ELISA, EM, IF, IHC
-
Anti-E1 protein [DC1.56]Chikungunya virus (CHIKV), Equine encephalitis virus, Mayaro virus (MAYV), Ross River (RRV), Sindbis virus (SINV)BLI, IP, ELISA, FC
-
Anti-E1 protein [DC1.7]Chikungunya virus (CHIKV), Mayaro virus (MAYV), Ross River (RRV), Sindbis virus (SINV)BLI, IP, neutralize, ELISA, FC
-
Anti-Ebola GP [h-13F6]EBOV (Zaire)IP, SPR, ELISA
-
Anti-Ebola Nucleoprotein [KZ51]Ebola Virus (Zaire, Ivory Coast, Reston, Sudan)IP, WB, ELISA, IF
-
Anti-Ebola surface glycoprotein [KZ52]Ebola (Zaire)crystallization, IP, NTRL, IF
-
Anti-Ebola virus VP35 protein; [6c5]Zaire ebolavirusIP, Western blot, IF
-
Anti-Envelop glycoprotein B [93k]human herpesvirus 3 (HHV-3, HHV3), Varicella zoster virus (VZV)IP, neutralize, WB
-
Anti-Envelope glycoprotein H and L [94]human herpesvirus 3 (HHV-3, HHV3), Varicella zoster virus (VZV)IP, neutralize, ELISA
-
Anti-Envelope glycoprotein H and L [rec-RC-IgG]Varicella zoster virus (VZV)IP, neutralize, IHC
-
Anti-Envelope protein [5A]Yellow Fever Viruscrystallography, functional assay, in vivo, IP, neutralize, ELISA
-
Anti-Genome polyprotein [C3]Poliovirus type 1in vitro, IP, neutralization
-
Anti-Genome polyprotein [MA28-7]Human enterovirusin vitro, IP, neutralization
-
Anti-Ghana Virus F [7C11-LY]Ghana virusIP, ELISA
-
Anti-Ghana Virus G [10C4-LY]Ghana virusIP, WB, ELISA
-
Anti-Ghana Virus G [10D5-LY]Ghana virusIP, WB, ELISA
-
Anti-glycoprotein E [19/1786]Tick-borne encephalitis virusCryo-EM, IP, Neurtalization, WB, ELISA
-
Anti-Glycoprotein E2 [AP33]Hepatitis C virus (HCV)functional assay, IP, neutralize, Block, ELISA
-
Anti-Glycoprotein E2 [HC-11]Hepatitis C virus (HCV)IP, neutralize, ELISA, FC, IF
-
Anti-Glycoprotein E2 [HC84.26.5D (HC26AM)]Hepatitis C virus (HCV)IP, neutralize, ELISA
-
Anti-Glycoprotein H [MAb 5]HCMVELIS, IP, RIA